Zolpidem and alpidem: two imidazopyridines with selectivity for omega 1- and omega 3-receptor subtypes
Langer, S.Z.; Arbilla, S.; Benavides, J.; Scatton, B.
Advances in Biochemical Psychopharmacology 46: 61-72
1990
ISSN/ISBN: 0065-2229 PMID: 1981304 Document Number: 354403
Document emailed within 1 workday
Related Documents
Kato, K.; Onodera, K.; Sakata, H.; Imai, M.; Kato, J.; Hodgson, W.J.; Abraham, N.G.; Kasai, S.; Mito, M. 1998: Fatty acid omega and (omega-1)-oxidation within intrasplenically transplanted fetal hepatocytes Transplantation 66(4): 441-445Bobryskin, I.D.; Kirpichnikov, M.P.; Kritsyn, A.M.; Mikhaĭlov, S.N.; Misharin, A.Iu. 1976: Nonglycosidic analogues of nucleotides. IX. Self-association of 9-(omega'-hydroxyalkyl) adenine omega'-phosphates in aqueous solutions Molekuliarnaia Biologiia 10(5): 1111-1115
Carnmalm, B.; Persson, M.L.; Ross, S.B.; Stjernström, N.E.; Ogren, S.O. 1975: Antidepressant agents. V. 1,1-Dimethyl-omega,omega-diphenylalkylamines Acta Pharmaceutica Suecica 12(2): 173-182
Malikova, N.A.; Krzhechkovskaia, V.V.; Marokko, I.N.; Mazo, V.K. 1995: The effect of fatty compounds with different ratios of the polyunsaturated fatty acids of the omega-3 and omega-6 families on the expression of food-related anaphylaxis, on the liver cytochrome P-450 system and on 17-hydroxycorticosteroid metabolism in guinea pigs Voprosy Pitaniia 4: 13-16
Holian, O.; Nelson, R. 1992: Action of long-chain fatty acids on protein kinase C activity: comparison of omega-6 and omega-3 fatty acids Anticancer Research 12(3): 975-980
Ilyukhina, V.A.; Sychev, A.G.; Shcherbakova, N.I.; Baryshev, G.I.; Denisova, V.V. 1982: The omega-potential: a quantitative parameter of the state of brain structures and of the individual. II. Possibilities and limitations of the use of the omega-potential for rapid assessment of the state of the individual Human Physiology 8(5): 328-339
V Tumiatti; Recanatini, M.; Minarini, A.; Melchiorre, C.; Budriesi, R.; Bolognesi, M.L. 1992: Affinity and selectivity at M2 and M3 muscarinic receptor subtypes of cyclic and oxygenated analogues of 4-DAMP Farmaco 47(9): 1133-1147
Paluchowska, M.H.; Kłodzińska, A.; Tatarczyńska, E.; Szaro, A.; Chojnacka-Wójcik, E. 1998: Effect of linking bridge modifications on the 5-HT1A receptor activity of some 4-(omega-benzotriazol-1-yl)alkyl-1-(2-methoxy-phenyl)piperazines Polish Journal of Pharmacology 50(4-5): 341-347
Williams, K. 1993: Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors Molecular Pharmacology 44(4): 851-859
Toselli, M.; Tosetti, P.; Taglietti, V. 1997: Mu and delta opioid receptor activation inhibits omega-conotoxin-sensitive calcium channels in a voltage- and time-dependent mode in the human neuroblastoma cell line SH-SY5Y Pflugers Archiv: European Journal of Physiology 433(5): 587-596
Learmonth, I.D.; Allen, P.E. 1996: The omega lateral approach to the hip Journal of Bone and Joint Surgery. British Volume 78(4): 559-561
2007: The power of 3. Omega-3 fatty acids Mayo Clinic Health Letter 25(8): 6
Ringskog, S. 1998: Omega-3 fatty acids against schizophrenia?! Lakartidningen 95(13): 1384
Tanskanen, A.; Tiihonen, J. 2004: Omega-3 fatty acids, new treatment for depression Duodecim; Laaketieteellinen Aikakauskirja 120(17): 2033-2035
Ribeiro, L. 1990: Prostaglandins and omega-3 acids in the prevention of atherosclerosis Arquivos Brasileiros de Cardiologia 54(4): 279-281
Morán, M. 1981: Venous omega-shaped little bow in diabetic retinopathy Ceskoslovenska Oftalmologie 37(6): 444-447
Richter, V.; Hamm, M. 2011: Value of omega-3 fatty acids in different periods of life Kinderkrankenschwester: Organ der Sektion Kinderkrankenpflege 30(5): 207-210
Powell, W.S. 1982: Measurement of prostaglandin omega-hydroxylase activity Methods in Enzymology 86: 168-179
2005: Omega-3 polyunsaturated fatty acids (Omacor) for hypertriglyceridemia Medical Letter on Drugs and Therapeutics 47(1221): 91
Kawai, R.; Fujita, S.; Suzuki, T. 1986: A new lidocaine metabolite, omega-diethylamino-2-hydroxymethyl-6-methylacetanilide Drug Metabolism and Disposition: the Biological Fate of Chemicals 14(2): 277-279